Back to Browse Journals » Neurobehavioral HIV Medicine » Volume 3

Expression of mannose binding lectin in HIV-1-infected brain: implications for HIV-related neuronal damage and neuroAIDS

Authors Singh KK, Nathamu S, Adame A, Alire TU, Dumaop W, Gouaux B, Moore DJ, Masliah E, and HNRC Group

Published Date May 2011 Volume 2011:3 Pages 41—52

DOI http://dx.doi.org/10.2147/NBHIV.S19969

Published 30 May 2011

Kumud K Singh1, Satyanarayana Nathamu1, Anthony Adame2, Tara U Alire1, Wilmar Dumaop2, Ben Gouaux3, David J Moore3, Eliezer Masliah2, and HIV Neurobehavioral Research Center Group
1Department of Pediatrics, 2Department of Neurosciences, 3Department of Psychiatry, University of California San Diego, La Jolla, CA, USA

Abstract: Mannose binding lectin (MBL) activates complement pathway that leads to pathogen opsonization and phagocytosis. MBL deficiency is linked to HIV transmission and disease progression. We sought to determine the role of MBL in HIV encephalitis (HIVE) by evaluating its presence and distribution in the HIV-1-infected brain and by assessing its association with monocyte chemoattractant protein-1 (MCP-1) expression. This retrospective study utilized archived post-mortem brain tissues obtained from 35 individuals enrolled in a longitudinal study as part of the California NeuroAIDS Tissue Network. MBL, MCP-1 and brain cell markers in post-mortem brain tissues with or without HIVE were evaluated using immunocytochemistry, immunofluorescence, confocal microscopy, and western blots. MBL was expressed in neurons, astrocytes, microglia, and oligodendrocytes of the frontal cortex of the HIV-1-infected brain. Overall, there were 30% to 40% more MBL-positive brain cells in HIVE vs non-HIVE cases (P = 0.01, paired t-test). Specifically, there was an increased MBL expression in the neuronal axons of HIVE cases. Also, western blots showed 3- to 4-fold higher levels of 78 kD MBL trimers in HIVE vs non-HIVE cases. This MBL-HIVE link was further confirmed by MBL associated higher MCP-1 expression in HIVE vs non-HIVE cases. HIV negative healthy individuals and normal or the gp120 transgenic mice did not show any differential MBL expression. Increased MBL expression in the major brain cell types, specifically in the neuronal axons of HIVE brain, and MBL associated higher MCP-1 expression in HIVE suggest that MBL could cause neuroinflammation and neuronal injury through MBL complement activation pathway.

Keywords: mannose binding lectin, HIV encephalitis, complement activation, neuroinflammation, neuroAIDS, MCP-1

Download Article [PDF] 

Creative Commons License This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution - Non Commercial (unported, v3.0) License. The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. Permissions beyond the scope of the License are administered by Dove Medical Press Limited. Information on how to request permission may be found at: http://www.dovepress.com/permissions.php

Readers of this article also read:

The Western Denmark Cardiac Computed Tomography Registry: a review and validation study

Nielsen LH, Nørgaard BL, Tilsted HH, Sand NP, Jensen JM, Bøttcher M, Diederichsen AC, Lambrechtsen J, Kristensen LD, Mickley H, Munkholm H, Gøtzsche O, Knudsen LL, Bøtker HE, Pedersen L, Schmidt M

Clinical Epidemiology 2015, 7:53-64

Published Date: 31 December 2014

Apolipoprotein-E genotype and human immunodeficiency virus-associated neurocognitive disorder: the modulating effects of older age and disease severity

Panos SE, Hinkin CH, Singer EJ, Thames AD, Patel SM, Sinsheimer JS, Del Re AC, Gelman BB, Morgello S, Moore DJ, Levine AJ

Neurobehavioral HIV Medicine 2013, 5:11-22

Published Date: 19 June 2013

Functionalized graphene oxide for clinical glucose biosensing in urine and serum samples

Veerapandian M, Seo YT, Shin H, Yun K, Lee MH

International Journal of Nanomedicine 2012, 7:6123-6136

Published Date: 18 December 2012

The neuro-ophthalmology of HIV-AIDS review of Neurobehavioral HIV Medicine

Sudhakar P, Kedar S, Berger JR

Neurobehavioral HIV Medicine 2012, 4:99-111

Published Date: 18 September 2012

Immune activation and neuropsychiatric symptoms in human immunodeficiency virus type 1 infection

Schroecksnadel S, Kurz K, Weiss G, Fuchs D

Neurobehavioral HIV Medicine 2012, 4:1-13

Published Date: 16 January 2012

Cognitive reserve masks neurobehavioral expression of human immunodeficiency virus-associated neurological disorder in older patients

Thames AD, Foley JM, Panos SE, Singer EJ, El-Saden S, Hinkin CH

Neurobehavioral HIV Medicine 2011, 3:87-93

Published Date: 31 October 2011

Gene expression for HIV-associated dementia and HIV encephalitis in microdissected neurons 1: preliminary analysis

Shapshak P, Duncan R, Duran EM, Farinetti F, Minagar A, Commins D, Rodriguez H, Chiappelli F, Kangueane P, Levine AJ, Singer E, Somboonwit C, Sinnott JT

Neurobehavioral HIV Medicine 2011, 3:53-78

Published Date: 19 July 2011

Anti-HIV-1 drug toxicity and management strategies

Sharma B

Neurobehavioral HIV Medicine 2011, 3:27-40

Published Date: 28 April 2011